Rosalind and Morris Goodman Cancer Research Centre

Note: This is the 2016–2017 edition of the eCalendar. Update the year in your browser's URL bar for the most recent version of this page, or click here to jump to the newest eCalendar.

Rosalind and Morris Goodman Cancer Research Centre

  • The Rosalind and Morris Goodman Cancer Research Centre
  • 1160 Pine Avenue West, Room 602
  • Montreal QC H3A 1A3
  • Telephone: 514-398-3535
  • Website: www.mcgillgcrc.com

The Rosalind and Morris Goodman Cancer Research Centre (GCRC) is a research centre that conducts internationally recognized fundamental and translational research in all areas of cancer. These research activities contribute to:

  1. improving the molecular understanding of cancer;
  2. improving disease management;
  3. training the next generation of cancer researchers; and
  4. conveying the importance of cancer research to the community.

The fundamental research approach adopted by the Centre is focused on better understanding the mechanisms involved in cancer initiation and progression and the pressing need to identify targets for clinical drug development. The research model involves identifying priority themes and establishing a critical mass of expertise within each theme. These themes include Breast Cancer, Metabolism and Cancer, Stem Cells and Signaling, DNA Replication/Repair and Apoptosis, and Embryonic Development and Cancer.

The GCRC has adopted a proactive and innovative approach to training the next generation of cancer researchers. In conjunction with the Experimental Medicine graduate program, the GCRC has implemented a specialized program, which is called the “Oncology Stream”. This program was conceived to give trainees the opportunity to acquire an integrated and broader perspective of basic and clinical research as it relates to cancer. Among other cancer-related courses, the students take a mandatory course: EXMD 635D1/EXMD 635D2 – Experimental/Clinical Oncology. This comprehensive course was created to expose trainees to a spectrum of different cancers, with topics ranging from diagnosis to current treatment and future drug development.

These courses are offered in the context of a CIHR funded training program termed the McGill Integrated Cancer Research Training Program. The training program includes other features such as seminar series featuring international authorities, workshops, and round table discussions. The Centre has also supported the establishment of a laboratory for therapeutic development to ensure that fundamental research results are translated towards clinical applications.

Programs, Courses and University Regulations—2016-2017 (last updated May. 18, 2016) (disclaimer)

Rosalind and Morris Goodman Cancer Research Centre Faculty

Rosalind and Morris Goodman Cancer Research Centre Faculty

Professor and Director
M. Park
Full Members
N. Beauchemin, M. Bouchard, P. Branton, T. Duchaine, A. Fuks, I. Gallouzi, V. Giguère, P. Gros, S. Huang, R. Jones, C. Krawczyk, L. McCaffrey, W. Muller, A. Nepveu, M. Park, A. Pause, J. Pelletier, G. Shore, P. Siegel, N. Sonenberg, J. St-Pierre, J. Teodoro, M. Tremblay, I. Watson, Y. Yamanaka, X.-J. Yang, M. Zannis-Hadjopoulos, G. Zogopoulos
Associate Members
U.D. Akavia, M. Alaoui-Jamali, S. Ali, G. Batist, P. Brodt, D. Cournoyer, D. Dankort, J. Dostie, L. Ferri, N. Jabado, S. Jothy, A. Koromilas, N. Lamarche-Vane, P. Laneuville, P. Lasko, C. Loiselle, K. Mann, W. Miller, L. Panasci, M. Pollak, J. Rak, R. Roy, M. Saleh, U. Saragovi, C.P. Stanners, M. Szyf, P. Tonin
Honorary Emeritus
M. Zannis-Hadjopoulos
Emeritus Professor
C.P. Stanners
Programs, Courses and University Regulations—2016-2017 (last updated May. 18, 2016) (disclaimer)
Faculty of Medicine—2016-2017 (last updated May. 18, 2016) (disclaimer)